| Pierce Peters, | |
|
200 1st St Sw, Rochester, MN 55905-0001 | |
| (507) 284-2511 | |
| Not Available |
| Full Name | Pierce Peters |
|---|---|
| Gender | Male |
| Speciality | Neurological Surgery |
| Location | 200 1st St Sw, Rochester, Minnesota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427518646 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | 67790 (Minnesota) | Primary |
| Entity Name | Mayo Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922074434 PECOS PAC ID: 6507778255 Enrollment ID: O20031103000285 |
News Archive
With our unique team and the power of the recent revolution in immersive reality technology, we are finally able to address these issues by providing a highly mobile, hands-on, realistic training platform that allows practitioners to learn or review complex surgical procedures without risking patient safety.
A Department of Health and Human Services report released Monday quantified the number of Americans with health insurance who no longer face these benefit limits.
Inflammatory processes occur in the brain in conjunction with stroke and neurological diseases such as Alzheimer's and Parkinson's disease. Researchers from Lund University and Karolinska Institutet in Sweden, in close cooperation with a group led by Professor José L. Venero at the University of Seville, have presented new findings about some of the 'key players' in inflammation.
Eisai Inc. today announced that it has submitted simultaneous regulatory applications for approval of eribulin mesylate (also known as E7389) for the treatment of locally advanced or metastatic breast cancer to agencies in Japan, the United States and the European Union (EU). Eribulin, a non-taxane microtubule dynamics inhibitor, is an investigational chemical compound discovered and developed by Eisai.
IMRIS Inc. ("IMRIS" or the "Company") today announced that it has gained regulatory approval from the Korea Food & Drug Administration permitting the Company to immediately begin marketing its 1.5 Tesla and 3.0 Tesla IMRISneuro systems in South Korea.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Pierce Peters, 200 1st St Sw, Rochester, MN 55905-0001 Ph: (507) 284-2511 | Pierce Peters, 200 1st St Sw, Rochester, MN 55905-0001 Ph: (507) 284-2511 |
News Archive
With our unique team and the power of the recent revolution in immersive reality technology, we are finally able to address these issues by providing a highly mobile, hands-on, realistic training platform that allows practitioners to learn or review complex surgical procedures without risking patient safety.
A Department of Health and Human Services report released Monday quantified the number of Americans with health insurance who no longer face these benefit limits.
Inflammatory processes occur in the brain in conjunction with stroke and neurological diseases such as Alzheimer's and Parkinson's disease. Researchers from Lund University and Karolinska Institutet in Sweden, in close cooperation with a group led by Professor José L. Venero at the University of Seville, have presented new findings about some of the 'key players' in inflammation.
Eisai Inc. today announced that it has submitted simultaneous regulatory applications for approval of eribulin mesylate (also known as E7389) for the treatment of locally advanced or metastatic breast cancer to agencies in Japan, the United States and the European Union (EU). Eribulin, a non-taxane microtubule dynamics inhibitor, is an investigational chemical compound discovered and developed by Eisai.
IMRIS Inc. ("IMRIS" or the "Company") today announced that it has gained regulatory approval from the Korea Food & Drug Administration permitting the Company to immediately begin marketing its 1.5 Tesla and 3.0 Tesla IMRISneuro systems in South Korea.
› Verified 7 days ago
Dr. Rahul Kumar, MD, PHD Neurological Surgery Medicare: May Accept Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Dr. Jennifer Lee Perez, MD, PHD Neurological Surgery Medicare: May Accept Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Fredric B Meyer, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Robert J Spinner, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Hirotaka Hasegawa, Neurological Surgery Medicare: Medicare Enrolled Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Noor Malik, MBBS Neurological Surgery Medicare: Medicare Enrolled Practice Location: 200 First Street Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Archis Ramkrishna Bhandarkar, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 |